• Aucun résultat trouvé

hepatitis B core-related antigen

Correlation of serum hepatitis B core-related antigen with hepatitis B virus total intrahepatic DNA and covalently closed circular-DNA viral load in HIV–hepatitis B coinfection

Correlation of serum hepatitis B core-related antigen with hepatitis B virus total intrahepatic DNA and covalently closed circular-DNA viral load in HIV–hepatitis B coinfection

... HBV, hepatitis B virus; HBeAg, hepatitis B “e” antigen; qHBcrAg, quantified hepatitis B core-related antigen; qHBsAg, quantified hepatitis ...

24

Association of Hepatitis B Core-Related Antigen and Antihepatitis B Core Antibody With Liver Fibrosis Evolution in Human Immunodeficiency Virus-Hepatitis B Virus Coinfected Patients During Treatment With Tenofovir

Association of Hepatitis B Core-Related Antigen and Antihepatitis B Core Antibody With Liver Fibrosis Evolution in Human Immunodeficiency Virus-Hepatitis B Virus Coinfected Patients During Treatment With Tenofovir

... of hepatitis B, including quantification of hepatitis B core-related antigen (qHBcrAg) and quantification of antihepatitis B core antibody (qAnti-HBc), has ...

9

CRISPR/Cas9 cleavage of viral DNA efficiently suppresses hepatitis B virus

CRISPR/Cas9 cleavage of viral DNA efficiently suppresses hepatitis B virus

... the core, polymerase and X ORFs, but numerous Cas9 target sites also exist in the S ORF ...surface antigen (HBsAg) into the medium, two reliable indicators for viral gene expression and replication ...be ...

10

DNA vaccine: a promising new approach for chronic hepatitis B therapy.: DNA Vaccine for hepatitis B therapy

DNA vaccine: a promising new approach for chronic hepatitis B therapy.: DNA Vaccine for hepatitis B therapy

... surface antigen has not resulted in measurable anti-WHs antibodies, whereas DNA immunization against core led to the induction of potent lymphoproliferative response which was further enhanced by ...

8

The Hep-CORE policy score: A European hepatitis C national policy implementation ranking based on patient organization data

The Hep-CORE policy score: A European hepatitis C national policy implementation ranking based on patient organization data

... viral hepatitis policy monitoring studies were conducted and highlighted the importance of addressing the viral hepatitis ...viral hepatitis policy and the increasing availability of all-oral, highly ...

15

Short approach toward the nonracemic A,B,E tricyclic core of calyciphylline B-type alkaloids

Short approach toward the nonracemic A,B,E tricyclic core of calyciphylline B-type alkaloids

... tricyclic core obtained in as few as nine linear synthetic steps. This core will be used as a common intermediate toward the synthesis of various members of the calyciphylline B-type alkaloids ...

4

In Situ Hepatitis C NS3 Protein Detection Is Associated with High Grade Features in Hepatitis C-Associated B-Cell Non-Hodgkin Lymphomas

In Situ Hepatitis C NS3 Protein Detection Is Associated with High Grade Features in Hepatitis C-Associated B-Cell Non-Hodgkin Lymphomas

... ated B-NHL as previously reported [ 3 ...lymphoma B-cells could constitute a major event in their transformation in large ...primary B-cells from patients infected with HCV and highlighted their ...

11

Toll-like receptor 2 senses hepatitis C virus core protein but not infectious viral particles.

Toll-like receptor 2 senses hepatitis C virus core protein but not infectious viral particles.

... dependent signaling: stably transfected CHO cells expressing human TLR2 and/or TLR4 on 18. their cell surface and a reporter gene allowing detecting ligand-induced TLR activati[r] ...

25

Specific core-shell approaches and related properties in nanostructured ferroelectric ceramics

Specific core-shell approaches and related properties in nanostructured ferroelectric ceramics

... the core-shell approaches that allow a subtle tuning of interface phenomena at different scales has been widely ...the core-shell approach devoted to the processing of nanostructured ferroelectric ...in ...

26

Antiviral-resistant hepatitis B virus: can we prevent this monster from growing?

Antiviral-resistant hepatitis B virus: can we prevent this monster from growing?

... patients with HBV infection. Sequential therapy with drugs that are cross-resistant will lead to stepwise selection of strains harboring increasing number of polymerase gene mutations conferring resistance to the first ...

22

Hepatitis B virus exploits C‐type lectin receptors to hijack cDC1s, cDC2s and pDCs

Hepatitis B virus exploits C‐type lectin receptors to hijack cDC1s, cDC2s and pDCs

... immunity. Hepatitis B virus (HBV) is a double-stranded DNA virus, which specifically infects hepatocytes and that can cause chronic liver diseases such as cirrhosis, liver failure and hepatocarcinoma 26 ...

25

100 kHz MAS Proton-Detected NMR Spectroscopy of Hepatitis B Virus Capsids

100 kHz MAS Proton-Detected NMR Spectroscopy of Hepatitis B Virus Capsids

... Keywords: solid-state NMR, fast MAS, proton detection, carbon detection, deuteration, hepatitis B virus, capsid, core protein INTRODUCTION Proton detection at 60 kHz magic-angle spinning (MAS) in 1.3 ...

11

Hepatitis B virus resistance to antiviral drugs: where are we going?

Hepatitis B virus resistance to antiviral drugs: where are we going?

... factors related to the virus (the number of mutations required to confer resistance, and their effect on viral fitness), the drug (mainly its antiviral potency) and the patient (treatment compliance and ...

8

A Seven-Year Retrospective Study on the Surveillance of Hepatitis B in Laos

A Seven-Year Retrospective Study on the Surveillance of Hepatitis B in Laos

... In the present study, there were twice more men than women attending CILM for HBV diagnosis and follow-up, whatever their geographical origin. This is similar to most studies on HBV prevalence, in which generally a ...

13

Chronic hepatitis B and HIV care: the key-role of the doctor-patient relationship

Chronic hepatitis B and HIV care: the key-role of the doctor-patient relationship

... À la suite de la consultation, un entretien anonyme était conduit avec le patient lorsqu’il avait donné son accord. Soixante-treize entretiens semi-directifs ont été menés : 33 avec des patients ayant une hépatite ...

10

Coinfection of hepatitis B and hepatitis Delta virus in Belgiumy: a multicenter BASL Study. Prospective epidemiolog and comparison with HBV mono-infection

Coinfection of hepatitis B and hepatitis Delta virus in Belgiumy: a multicenter BASL Study. Prospective epidemiolog and comparison with HBV mono-infection

... The Asia-Pacific region, an area known to be endemic for hepatitis B, interestingly has shown a decline in the prevalence of hepatitis delta [reviewed by Abbas et al., 2010]; most of the data ...

5

Synthesis of constrained tricyclic nucleosides and the core of nagilactone B

Synthesis of constrained tricyclic nucleosides and the core of nagilactone B

... Accordingly, alcohol 1.98 (Scheme 1.18) was oxidized to the corresponding carboxylic acid with chromic acid (the product of chromium trioxide mixed with sulfuric acid), 116 which was subsequently converted to ...

410

Identification and Characterization of TspA, a Major CD4+ T-Cell- and B-Cell-StimulatingNeisseria-Specific Antigen

Identification and Characterization of TspA, a Major CD4+ T-Cell- and B-Cell-StimulatingNeisseria-Specific Antigen

... University of Nottingham Faculty of Medicine and Health Sciences, University Hospital, Nottingham NG7 2UH, 1 and Central Public Health Laboratory, London NW9 5HT, 2 United Kingdom Received 9 December 1998/Returned for ...

9

Remodeling of B-Cell Subsets in Blood during Pegylated IFNα-2a Therapy in Patients with Chronic Hepatitis B Infection

Remodeling of B-Cell Subsets in Blood during Pegylated IFNα-2a Therapy in Patients with Chronic Hepatitis B Infection

... modulates B-cell subset distribution without affecting HBV- specific immunoglobulins We then assessed the impact of Peg-IFN- α therapy on B-cell subsets by analyzing the alter- ations in their frequencies ...

18

New virologic tools for management of chronic hepatitis B and C.: New Virological Tools

New virologic tools for management of chronic hepatitis B and C.: New Virological Tools

... Bettman B, Bibillo A, Bjornson K, Chaudhuri B, Christians F, Cicero R, Clark S, Dalal R, Dewinter A, Dixon J, Foquet M, Gaertner A, Hardenbol P, Heiner C, Hester K, Holden D, Kearns G, Kong X, Kuse R, ...

41

Show all 4612 documents...

Sujets connexes